WASHINGTON, Nov. 18, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) VNDA today announced that it will participate at the following upcoming investor conferences in November 2019:
The Stifel 2019 Healthcare Conference in New York City on Tuesday, November 19, 2019. A corporate presentation is scheduled for 9:10 a.m. Eastern Time.
The Jefferies 2019 London Healthcare Conference in London, England on Wednesday, November 20, 2019. A corporate presentation is scheduled for 10:00 a.m. Greenwich Mean Time (5:00 a.m. Eastern Time).
The corporate presentations given at the Stifel and Jefferies conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investors page. Please connect to the website several minutes prior to the start of the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Corporate Contact:
AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
